Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow support (Q72454726)
Jump to navigation
Jump to search
scientific article published on 01 June 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow support |
scientific article published on 01 June 1994 |
Statements
Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow support (English)
Shpall EJ
Stemmer SM
Hami L
Franklin WA
Shaw L
Bonner HS
Bearman SI
Peters WP